Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized blinded dose-comparison trial of VZV-7D varicella vaccine in children
ChiCTR2000034434Phase 2Recruiting
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Jul 2020
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of vzv-7d and varicella vaccine live in chickenpox (4 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoints: Serum anti-varicella virus specific IgG antibody, Peripheral blood VZV-specific T-cell immune response (IFN-gamma after VZV stimulation) and 4 more. Started Jul 2020; status: recruiting.
02
Drugs
vzv-7dvaricella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on ChiCTR2000034434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034434.